Page last updated: 2024-11-05

zonisamide and Pharyngitis

zonisamide has been researched along with Pharyngitis in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Pharyngitis: Inflammation of the throat (PHARYNX).

Research Excerpts

ExcerptRelevanceReference
" The most common adverse events were somnolence, headache, dizziness, and nausea during the titration phase and headache and pharyngitis during the fixed-dose assessment phase."2.71Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. ( Bitenskyy, V; Brodie, MJ; Duncan, R; Lucas, C; Solyom, A; Vespignani, H, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodie, MJ1
Duncan, R1
Vespignani, H1
Solyom, A1
Bitenskyy, V1
Lucas, C1
Kijima, A1
Inui, S1
Nakamura, T1
Itami, S1
Katayama, I1

Trials

1 trial available for zonisamide and Pharyngitis

ArticleYear
Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Epilepsia, 2005, Volume: 46, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Dose-Response Relationship, Drug; Doub

2005

Other Studies

1 other study available for zonisamide and Pharyngitis

ArticleYear
Does drug-induced hypersensitivity syndrome elicit bullous pemphigoid?
    Allergology international : official journal of the Japanese Society of Allergology, 2008, Volume: 57, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Carbamazepine; Drug Hypersensitivity; Female; Humans; Immunosuppressive

2008